CBL proteins exert anti-tumor effects by facilitating the degradation of several well-known tyrosine kinases with tumor-promoting roles, such as EGFR and HER2 (Feng et al. 2013; Li et al. 2018). The gene discussed is ERBB2; the disease is neoplasm.